Clinical Studies on Iron Kinetics : II. Iron Kinetics Studies in Patients with Malignant Neoplasms : with Special Reference to Ferrokinetics and 59Fe Labeled Iron-Dextran Studies
Clinical studies explore iron dynamics in cancer, revealing insights into anemia mechanisms and iron release issues.
Key Points
This research aims to understand how iron metabolism is altered in cancer patients, particularly focusing on erythropoiesis and reticulo-endothelial cell function.
Conducted ferrokinetic studies using 59Fe-citrate to assess red cell production rates.
Used 59Fe labeled iron-dextran to evaluate iron utilization by reticulo-endothelial cells.
Enumerated sideroblasts in bone marrow smears to gauge iron levels in erythroblasts.
Increased rate of erythropoiesis was found in cancer patients compared to normal levels.
A decreased utilization of radioiron for hemoglobin synthesis was observed in malignant diseases.
Bone marrow sideroblasts levels were significantly reduced, averaging 28 percent in cancer patients.